Immunosuppressive therapy in renal transplantation.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D000941:Antigens; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004285:Dogs; D004322:Drainage; D005069:Evaluation Studies as Topic; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000401:mortality; D007239:Infections; D016030:Kidney Transplantation; D037102:Lectins / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010640:Phenothiazines / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011817:Rabbits; D011830:Radiation Effects; D013897:Thoracic Duct / Q000601:surgery; D014184:Transplantation, Homologous
D000925:Anticoagulants; D000941:Antigens; D000961:Antilymphocyte Serum; D005938:Glucocorticoids; D037102:Lectins; D010640:Phenothiazines; D003561:Cytarabine; D003609:Dactinomycin; D011344:Procarbazine; D003520:Cyclophosphamide; D001215:Asparaginase; D001379:Azathioprine; D008727:Methotrexate